India gentamycin market is expected
to grow at a formidable rate during the forecast period. The India gentamycin
market is driven by the growing prevalence of animal diseases outbreaks.
Gentamycin finds maximum usage in veterinary medicine. Additionally, gentamycin
is used in the treatment of several human diseases and infections including
urinary tract infections, renal disorders, sepsis, among others. This in turn
is expected to positively influence the market growth during the forecast
period. Besides, the high efficacy and affordability of the medication are
further expected to fuel the market growth through FY2026.
The India gentamycin market
is segmented based on source, form, route of administration, distribution
channel, application, company and region. Based on route of administration, the
market can be categorized into eye drops, tablet, capsule, syrup, injection,
cream, gel, ointment and others. The intravenous route is expected to witness
significant growth in the market through FY2026 since a large dose of drug can
be administered using this route of drug administration. Also, this is the most
effective route of administration for the drugs that are not orally absorbed
with 100% bioavailability.
The major players operating in the
India gentamycin market are Taj Pharmaceuticals Ltd., Bayer India Ltd., Zydus Cadila
Healthcare Ltd., Neon Laboratories Ltd., Hetero Healthcare Ltd., Gracure
Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd.,
Fresenius Kabi India Pvt. Ltd., Nestor Pharmaceuticals Ltd. and others. Major
companies are developing advanced technologies, receiving approvals from
regulatory bodies and launching new products in order to stay competitive in
the market. Other competitive strategies include mergers & acquisitions and
new product developments.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
gentamycin market from FY2016 to FY2019.
- To estimate and forecast the market size of India
gentamycin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India gentamycin market
based on source, form, route of administration, distribution channel,
application, company and regional distribution.
- To identify dominant region or segment in the India
gentamycin market.
- To identify drivers and challenges for India gentamycin
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
gentamycin market.
- To identify and analyze the profile of leading
players operating in India gentamycin market.
- To identify key sustainable strategies adopted
by market players in India gentamycin market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India gentamycin market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Gentamycin manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to gentamycin
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India gentamycin market has
been segmented into following categories, in addition to the industry trends
which have also been detailed below:
- India Gentamycin Market, By Source:
- In-House
- Contract Manufacturing Organizations
- India Gentamycin Market, By Form:
- Eye Drops
- Tablet
- Capsule
- Syrup
- Injection
- Cream
- Gel
- Ointment
- Others
- India Gentamycin Market, By Route of
Administration:
- Ophthalmic
- Intravenous
- Topical
- Oral
- Others
- India Gentamycin Market, By Distribution Channel:
- India Gentamycin Market, By Application:
- Bacterial Infection
- Urinary Tract Infection
- Sepsis
- Meningitis
- Skin or Soft Tissue Infection
- Upper Respiratory Tract Infection
- Others
- India Gentamycin Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India gentamycin market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India Gentamycin market is
an upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]